|
|
||||||||
J. D. Stockand is in the Department of Physiology, University of Texas Health Science Center San Antonio, San Antonio, Texas 78284-7756. D. C. Eaton is at the Center for Cell and Molecular Signaling, Department of Physiology, Emory University School of Medicine, Atlanta, Georgia 30322; R. S. Edinger and J. P. Johnson are in the Renal-Electrolyte Division, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213.
| Abstract |
|---|
| Introduction |
|---|
|
|
|---|
Figure 1
shows the idealized cell model of a Na+ reabsorbing epithelial cell, such as the principal cell. The rate-limiting step in electrogenic Na+ reabsorption is entry across the luminal plasma membrane. Entry of Na+ is down its electrochemical gradient through a Na+-selective ion channel. This channel has been cloned and named the epithelial Na+ channel (ENaC). ENaC in principal cells is well characterized (for recent reviews, see Refs. 4 and 5). Abnormal ENaC activity resulting from channel mutation or dysfunctional hormone signaling results in improper regulation of blood pressure due to plasma fluid volume imbalances. Aldosterone modulates the activity of ENaC to regulate the rate of discretionary Na+ reabsorption. Serosal Na+-K+-ATPases maintain the electrochemical gradient at the expense of chemical energy (ATP catabolism). Thus the active transport of Na+ across the serosal membrane allows for the restrictive diffusion across the luminal membrane, with the activity of the luminal entry pathway being rate limiting and modulated in response to aldosterone.
|
The laboratory of Johnson was the first to show that aldosterone increases methylation of both lipids and proteins in epithelia (reviewed in Ref. 10). The time course of this methylation (4 h) correlated well with the early actions of aldosterone. Moreover, methylation-promoting agents, such as S-adenosyl-L-methionine (SAMe, also abbreviated SAM and AdoMet), increased Na+ entry across the luminal membrane. That the magnitude of increase in Na+ transport was similar with aldosterone and SAMe and that aldosterone and SAMe were not additive suggests that both work through the same signaling pathway. Several other investigators have also now shown that aldosterone increases substrate methylation in epithelia (9, 10, 12). Also confirmed was that SAMe increases Na+ channel activity (4, 6, 9). Several investigators have also reported that a pharmacological inhibitor of methylation attenuates aldosterone-induced Na+ reabsorption, showing further a dependency of transport on methylation (4, 10, 11).
| Biological methylation |
|---|
|
|
|---|
|
The best-described methylation involved in signal transduction in eukaryotes is methyl esterification of proteins terminating with carboxyisoprenylcysteines. Small, monomeric G proteins, such as p21ras, nuclear lamin B, cyclic nucleotide phosphodiesterase, and subunits of trimeric G proteins all contain such carboxy-terminal cysteine isoprenoids (3). Methylation of these signaling molecules controls their activity or cellular localization, with Ras being specifically localized to the inner leaflet of the plasma membrane upon methyl esterification. Reversible methylation of other signaling proteins, such as phosphoprotein phosphatase 2A (PP2A), has also been reported (3). For PP2A, methylation of a carboxyleucine is catalyzed by an enzyme different from that leading to modification of carboxyisoprenylcysteine.
| Aldosterone-induced methyltransferase is necessary for Na+ reabsorption |
|---|
|
|
|---|
Aldosterone induces both a GTP-dependent increase in formation of peptide methyl esters in vitro and a GTP-dependent methylation of a 95-kDa protein substrate in vivo (6, 9, 10, 12). PCMT is the only protein methyltransferase well documented to be stimulated by GTP.
The recent cloning of the gene coding PCMT and the production of a specific antibody against PCMT allowed for the direct investigation of the hypothesis that this transferase is involved in mediating aldosterone-induced Na+ transport. Aldosterone induces PCMT activity without affecting enzyme number, suggesting that this methyltransferase is not an aldosterone-induced protein but that it ultimately is regulated by an AIP (12). Aldosterone-induced activation of PCMT results in increased protein methylation in vivo. Overexpression of PCMT potentiates aldosterone-induced Na+ transport but does not mimic all steroid action, suggesting that PCMT activity is not rate limiting for Na+ transport in the absence of steroid but that it can become limiting in the presence of steroid. This observation is interesting because it suggests that either a regulator or effector of PCMT, or a permissive parallel signaling pathway, is limiting in the absence of steroid.
| Substrates of aldosterone-stimulated methyltransferase relevant to Na+ reabsorption |
|---|
|
|
|---|
The initial suggestion that ßENaC might be a methylation substrate were findings showing that a 90- to 95-kDa apical membrane protein (possibly part of the luminal Na+ channel) was methylated in response to steroid treatment (6, 10). Glycosylated ßENaC is ~9095 kDa. We have shown that aldosterone stimulates methylation of ßENaC in membranes of renal epithelial cells in a GTP-dependent manner (9). Also consistent with ßENaC being a substrate for steroid-stimulated methylation are in vivo results showing that aldosterone induces methylation of proteins ranging from 85 to 95 kDa (1). Moreover, in vitro translated ßENaC, but not
- or
ENaC, proved to be a substrate for methylation by enzymes contained in a membrane preparation from renal epithelial cells (9). Further evidence that supports ßENaC as a methylation substrate are electrophysiological results documenting activation of ENaC in excised patches (4) and reconstituted in planar lipid bilayers (6, 9) by addition of SAMe to the intracellular face of the ion channel. Both of these electrophysiological maneuvers disrupt cellular signaling pathways by isolating integral and peripheral plasma membrane proteins from other cellular proteins, leaving only the ion channel and closely associated proteins available for methylation. If ßENaC is indeed the substrate (or one of the substrates) of aldosterone-stimulated methylation, these electrophysiological studies suggest the site to be on the intracellular portion of the molecule. Interestingly, there is no clear O-carboxymethylation consensus site in either the carboxy or amino terminal, putative cytosolic domains of ßENaC. However, the carboxy terminus of ßENaC contains arginine residues flanked by a proline-rich region. Arginines in such a motif can be N-methylated by PRMT. At present, though, it is unclear which amino acid(s) in ßENaC is targeted for methylation.
Another possible substrate for aldosterone-induced methylation is p21ras. In renal epithelia, methyl esterification of Ras was recently shown to be elevated ~14-fold in response to aldosterone (1). Methyl esterification is required for proper membrane localization of Ras. Other recent results show that Ras translocates to the plasma membrane within 4 h in response to steroid treatment (13). Further support for the idea that aldosterone-sensitive Ras methylation is important for Na+ transport are two observations: 1) PCMT, which methylates carboxy-terminal CAAX (cysteine, aliphatic residue, any residue) consensus sites (such as that of Ras), is activated by steroid and necessary for transport, and 2) the Ras protein is necessary for Na+ transport and ENaC activity in renal epithelia (1, 12, 13).
Interestingly, K-Ras is an aldosterone-induced protein necessary for aldosterone-stimulated Na+ reabsorption (7, 13). Downstream effectors of Ras signaling are also stimulated by aldosterone in a Ras-dependent manner. The ultimate effect of aldosterone-activated K-Ras is to sustain activity of the luminal Na+ channel. Overexpression of K-Ras increases basal Na+ reabsorption in the absence of steroid, suggesting that the levels of K-Ras are limiting for regulated transport in the absence of aldosterone. Recall that overexpression of PCMT failed to affect Na+ transport in the absence of steroid but did potentiate aldosterone action, suggesting that PCMT is not limiting in the absence of steroid but becomes limiting in its presence. These two observations together suggest that at rest the levels of K-Ras are limiting and that subsequent to aldosterone-increased K-Ras levels the aldosterone-sensitive PCMT activity becomes limiting. Thus activation of PCMT by aldosterone converges with steroid induction of Ras synthesis. This methylated Ras, localized to the apical membrane, is then able to affect ENaC. The mechanism by which methylated Ras regulates ENaC remains to be elucidated.
Another candidate protein substrate for aldosterone-relevant methylation is PP2A. Although no direct evidence supports the notion that PP2A is methylated in response to aldosterone, this protein is a known substrate for methylation and may be important to the proper regulation of ENaC.
Figure 3
shows that the aldosterone-induced activity of ENaC in cell-attached patches created on renal epithelial cells with decreased methyltransferase activity is markedly lower than the activity in cells with normal transferase activity. Moreover, the activity in transferase-decreased cells treated with steroid is similar to that in normal cells not treated with steroid. Thus these and other direct single-channel experiments (4, 6, 9) demonstrate that the final effector of aldosterone-relevant methylation is the apical Na+ channel. What remains unclear are the effectors intermediate to methyltransferase and ENaC.
|
It is also possible that methylated Ras directly regulates ENaC gating or insertion/retrieval. Alternatively, Ras could signal to ENaC through a number of different effectors. Phosphatidylinositol 3-kinase (PI3-kinase) is one of only a few well-documented first effectors of Ras. Interestingly, PI3-kinase modulates ENaC activity (8). Aldosterone, via Ras signaling, also activates the kinase cascade associated with cell proliferation and differentiation (13). It is possible that any of these kinases and modified gene expression in response to activation of the kinase cascade could regulate ENaC activity. However, this latter possibility is not likely, since ENaC can be activated by methylation when the channel is physically separated from the nucleus.
| Mechanisms of aldosterone induction of methyltransferase |
|---|
|
|
|---|
The predominate intracellular methyl-donating molecule, SAMe, is metabolized to S-adenosyl-L-homocysteine (SAH) during substrate methylation. This endproduct is a potent feedback inhibitor of all methylation reactions. The only enzyme in vertebrates capable of SAH hydrolysis is S-adenosyl-L-homocysteine hydrolase (SAHHase). Thus regulation of cellular SAH levels by SAHHase may be an important site for controlling methylation and possibly Na+ transport. Several laboratories have reported that inhibition of SAHHase activity decreases aldosterone-induced Na+ influx, current, and Na+ channel activation (4, 10). Recently, we described the cellular mechanisms of regulation of Na+ transport by SAHHase (11). Aldosterone induces SAHHase activity within 4 h. This increase in activity results in increased SAH hydrolysis, which leads to a concomitant increase in substrate methylation and Na+ reabsorption. Thus aldosterone induction of SAHHase activity is a form of metabolic regulation of the methylation reaction relevant to Na+ transport.
In summary, aldosterone stimulates a methylation reaction that is necessary for the early phase of regulated Na+ reabsorption (Fig. 4
). The ultimate effector of steroid-induced methylation is the luminal Na+ channel. However, a number of intriguing questions remain concerning this signal transduction pathway. Although aldosterone stimulates diverse methyltransferase activities (leading to increased phospholipid and protein methylation), the mechanism of steroid action is indirect with no apparent change in transferase protein levels. The pathways involved in regulation of transferase activity remain to be elucidated but likely involve modulation of SAHHase activity and post-translational modification of the various methyltransferases. Although PCMT is critical to Na+ reabsorption, the roles for other methyltransferases remain to be investigated. Thus the specific transferases relevant to Na+ reabsorption and the actions of aldosterone on these proteins need to be further defined. Both K-Ras, an aldosterone-induced protein, and ßENaC are methylated in response to aldosterone. The mechanism of ENaC activation by these methylated proteins has not been investigated. Moreover, a role for other methylation substrates (like PP2A) in aldosterone signaling needs to be pursued further, and effectors intermediate from the methylation substrate to ENaC need to be elucidated. The actions of aldosterone on epithelia are known to be pleotropic, with early and late phases. Methylation reactions may be involved in more than one phase of aldosterone signal transduction.
|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
D. W. Good Nongenomic Actions of Aldosterone on the Renal Tubule Hypertension, April 1, 2007; 49(4): 728 - 739. [Full Text] [PDF] |
||||
![]() |
R. S. Edinger, J. Yospin, C. Perry, T. R. Kleyman, and J. P. Johnson Regulation of Epithelial Na+ Channels (ENaC) by Methylation: A NOVEL METHYLTRANSFERASE STIMULATES ENaC ACTIVITY J. Biol. Chem., April 7, 2006; 281(14): 9110 - 9117. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Schafer Abnormal regulation of ENaC: syndromes of salt retention and salt wasting by the collecting duct Am J Physiol Renal Physiol, August 1, 2002; 283(2): F221 - F235. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |